SCHEMBL20847604

SCHEMBL20847604

Fc1c(F)c(F)c(SN(Cc2ccc(Cl)cc2)C2CC2)c(F)c1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 3/20 0.38
SLC6A4 P31645 3/20 0.38
SLC6A3 Q01959 3/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2D6 P10635 2/20 0.38
CYP2C9 P11712 2/20 0.38
CYP2C19 P33261 2/20 0.38
CYP1A2 P05177 1/20 0.38
LSS P48449 2/20 0.35
POLB P06746 1/20 0.34
HDAC6 Q9UBN7 5/20 0.33
HDAC8 Q9BY41 4/20 0.33
P2RX7 Q99572 1/20 0.33
HDAC11 Q96DB2 2/20 0.32
DRD2 P14416 2/20 0.32
DRD4 P21917 2/20 0.32
HDAC3 O15379 2/20 0.32
AGER Q15109 1/20 0.32
DRD3 P35462 1/20 0.32
PSEN1 P49768 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20847664 0.85 ESR1 (0.38) HDAC6HDAC8HDAC11HDAC3
SCHEMBL20847477 0.84 SLC6A2 (0.39) SLC6A2SLC6A4LSSHDAC6HDAC8
SCHEMBL20847602 0.83 AGER (0.38) SLC6A2SLC6A4SLC6A3POLBHDAC6
SCHEMBL20847642 0.82 SLC6A4 (0.35) SLC6A2SLC6A4SLC6A3POLBHDAC6
SCHEMBL20847669 0.82 AGER (0.40) SLC6A2SLC6A4SLC6A3CYP3A4CYP2D6
SCHEMBL20847650 0.82 ALDH1A1 (0.35) CYP3A4CYP2D6CYP2C9CYP2C19CYP1A2
SCHEMBL20847622 0.81 L3MBTL1 (0.40) DRD2PYCR1
SCHEMBL20847740 0.81 NSD2 (0.47) SLC6A2SLC6A4SLC6A3
SCHEMBL20847575 0.81 AGER (0.42) SLC6A2SLC6A4SLC6A3CYP3A4CYP2D6
SCHEMBL20847775 0.80 KMT2A (0.44) HDAC6HDAC8HDAC11HDAC3AGER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019056120-A1 PENTAFLUOROPHENYL SULFONAMIDE COMPOUNDS, COMPOSITIONS AND USES THEREOF DALRIADA THERAPEUTICS INC. (CA) 2019-03-28 WO disclosed